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Alterations in oral bacterial 
communities are associated 
with risk factors for oral and 
oropharyngeal cancer
Daniela Börnigen1,2,8,9, Boyu Ren1,2, Robert Pickard3, Jingfeng Li3, Enver Ozer3,  
Erica M. Hartmann  4,5, Weihong Xiao3, Timothy Tickle2, Jennifer Rider6, Dirk Gevers2,  
Eric A. Franzosa  1,2, Mary Ellen Davey7, Maura L. Gillison3 & Curtis Huttenhower  1,2
Oral squamous cell carcinomas are a major cause of morbidity and mortality, and tobacco usage, 
alcohol consumption, and poor oral hygiene are established risk factors. To date, no large-scale 
case-control studies have considered the effects of these risk factors on the composition of the oral 
microbiome, nor microbial community associations with oral cancer. We compared the composition, 
diversity, and function of the oral microbiomes of 121 oral cancer patients to 242 age- and gender-
matched controls using a metagenomic multivariate analysis pipeline. Significant shifts in composition 
and function of the oral microbiome were observed with poor oral hygiene, tobacco smoking, and 
oral cancer. Specifically, we observed dramatically altered community composition and function after 
tooth loss, with smaller alterations in current tobacco smokers, increased production of antioxidants 
in individuals with periodontitis, and significantly decreased glutamate metabolism metal transport 
in oral cancer patients. Although the alterations in the oral microbiome of oral cancer patients were 
significant, they were of substantially lower effect size relative to microbiome shifts after tooth loss. 
Alterations following tooth loss, itself a major risk factor for oral cancer, are likely a result of severe 
ecological disruption due to habitat loss but may also contribute to the development of the disease.
Head and neck squamous cell carcinomas are a major cause of cancer morbidity and mortality, with an estimated 
incidence of 549,000 cases worldwide in 20081. The majority of these are oral cancers arising in the oral cavity and 
oropharynx, for which tobacco usage, betel chewing, alcohol consumption, and human papillomavirus (HPV) 
infection are established risk factors2–9. Case-control studies have also reported associations between oral can-
cer and measures of chronic poor oral hygiene (e.g. loose or missing teeth, infrequent tooth brushing or dental 
visits)5,10–20, even among non-smokers and non-drinkers21,22. When combined with tobacco or alcohol use, poor 
oral hygiene acts synergistically to increase the risk associated with either exposure alone21,22 and leads to chronic 
infection and inflammation, both of which are increasingly recognized in the pathogenesis of cancer23–25 and 
as factors in carcinogenic feedback loops incorporating the resident microbiota. Although a few recent studies 
characterized the interactions of these epidemiological risk factors for oral cancer with the microbiome, they were 
limited by sample size and different experimental approaches26–29.
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Apropos, human microbiome studies have recently characterized the structure and function of the micro-
bial communities in different regions of the human body during health30 and disease states, including the oral 
cavity31–35. Indeed, specific microbial communities are associated with periodontitis36–38 and dental caries39–41. 
Preliminary small studies have also found different microbial communities in samples collected from the surface 
of oral cancers and normal tissues matched from the same subject42–44. A sample of 15 oral cancers, for exam-
ple, were enriched for Firmicutes and Actinobacteria relative to matched samples45 and a single array-based 
case-control study reported elevated counts of a few bacteria in oral cancer (e.g. Capnocytophaga gingivalis, 
Provatella melaningtoenica, and Streptococcus mitis)46. Larger-scale epidemiologically designed cohorts are 
needed to verify these structural associations, however, and especially to provide well-powered investigations of 
host-microbe-environment interactions in oral cancer.
In this study, we thus compared the oral microbiome in 121 oral cancer cases and 242 matched controls using 
multivariate analysis targeted at microbial taxonomic and inferred functional profiles. We evaluated associa-
tions between lifestyle factors (alcohol and tobacco use), health characteristics (history of periodontitis, tooth 
status), case-control status, and the composition and function of oral microbial communities (Table 1). Our 
results revealed strong shifts in composition and function associated with tooth status, with more modest shifts 
during tobacco smoking and oral cancer, both while additionally incorporating environmental factors into the 
analysis. Microbial community effects included a loss of ecological diversity and increased glutamate metabolism 
in tobacco smoking individuals, disruptions in both structure and function in individuals after tooth loss, and a 
decrease in glutamate metabolism and metal transport in cancer cases. Other lifestyle and health characteristics, 
including alcohol consumption, history of periodontitis, and tumor HPV status, were associated only with minor 
microbial effects in this population. We conclude that alterations in the structure, diversity, and function of the 
oral microbiome occur in association with established risk factors for oral cancer, especially after complete tooth 
loss; these alterations may contribute to disease development but are likely due to severe ecological disruption 
and habitat loss.
Results
Study population and sample characteristics. Oral rinse samples were collected for microbiome anal-
ysis from 121 cases diagnosed with oral cavity (n = 43), oropharynx (n = 64), or unknown primary (n = 5) squa-
mous cell carcinoma (Table 1). A total of 242 controls were age (5-year intervals) and gender matched to cases at 
a 2:1 ratio within six months of case enrollment. The cohort was predominantly male, with median age 58 years 
(IQR 53–66). Cases were more likely than controls to be current tobacco users or cigarette smokers. Complete 
tooth loss and a history of periodontitis were also more common among cases than controls.
The structure and function of the oral microbiome is associated with oral cancer status. A 
comparison of the oral microbiome in cancer cases and controls showed changes both in structure (16 signif-
icantly differentially abundant clades) and in function (25 metabolic pathways, Supplementary Datasets 4 and 
5 and Fig. 1). Tests were performed using a multivariate generalized linear model incorporating case/control 
status, tooth loss, tumor HPV status (for cases), periodontal disease, tobacco usage, alcohol consumption, 
and other covariates, with microbial abundances as outcome and FDR-corrected significance at q < 0.25; see 
Methods. Taxa belonging to the genus Dialister occurred at higher relative abundances in cases, whereas the 
orders Actinomycetales and Lactobacillales were significantly under-represented in oral cancer (Fig. 1a). No sig-
nificant differences in microbial presence/absence were observed between cases and controls, in contrast to these 
changes in specific clades’ relative abundances.
Analysis of predicted functional modules indicated that genes involved in synthesis of lipopolysaccha-
rides (KEGG47 M00063: CMP-KDO biosynthesis and M00064: ADP-L-glycero-D-manno-heptose biosynthe-
sis) were more abundant in cases than in controls (Fig. 1b). Pathways involved in LPS transport (e.g. M00250: 
Lipopolysaccharide transport) decreased, possibly reflecting a shift to a higher proportion of a distinct group 
of Gram-negative bacteria, e.g. a shift to higher levels of Dialister. Other functional modules, in particular the 
relative abundance of genes involved in amino acid transport and synthesis were altered; specifically an increase 
in serine synthesis (M00020: Serine biosynthesis, glycerate-3P => serine) was detected, while glutamate uptake 
(M00233: Glutamate transport), synthesis of threonine from aspartate (M00018: Threonine biosynthesis, aspar-
tate => homoserine => threonine), and synthesis of ornithine from glutamate (M00028: Ornithine biosyn-
thesis, glutamate => ornithine) were at a lower relative abundance in oral cancer subjects. As these pathways 
are generally involved in oxidative energy harvest from TCA cycle products, particularly in combination with 
reduced LPS transport, this may reflect a shift toward anaerobic microbes and/or metabolism in the oral cancer 
microenvironment.
Community functional dysbioses during oral cancer were also reflected in a predicted increase in the syn-
thesis and transport of vitamins and cofactors involved in metabolism, e.g. biotin and thiamine (M00123: Biotin 
biosynthesis, pimeloyl-ACP/CoA => biotin, M00127: Thiamine biosynthesis, AIR => thiamine-P/thiamine-2P). 
There was also a shift in iron uptake systems (M00190: Iron(III) transport, M00243: Manganese/iron transport), 
iron (M00243: Manganese/iron transport, M00248: ABC transporter), zinc, and manganese transport (M00244: 
Putative zinc/manganese transport). This suite of depleted metal transporters, primarily iron, may also reflect 
the need for fewer of these cofactors in a less-oxidative metabolic environment. Lastly, a decrease in transport 
systems for osmoprotectants (M00209: Osmoprotectant transport) was predicted, which may reflect a commu-
nity response to changes in the osmolarity of saliva. Epithelial cell death and the resultant release of cell constit-
uents, including amino acids, may be higher in cancer patients, hence synthesis of osmoprotectants may not be 
necessary.
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Lower microbial diversity and loss of function after tooth loss. We observed a dramatic decrease 
in a broad range of clades in association with total tooth loss (i.e. no natural teeth remaining), comprising 122 
clades (from Actinomycetaceae, Corynebacterium, Rothia, Prevotella, Flavobacteriales, Streptococcaceae, 
Fusobacteriales, and Proteobacteria; see Supplementary Dataset 4, Fig. 2). This represented the largest single 
association of the microbiome with clinical, demographic, or environmental factors in this cohort (Fig. 3). The 
striking difference between even one versus no natural teeth remaining likely corresponds to a loss of habitat, 
since the epithelium-tooth interface is a key site for bacterial colonization in the oral cavity. Individuals with total 
tooth loss had less diverse oral microbiomes that were less similar to each other than in individuals with good oral 
hygiene, revealing a significant microbial community profile shift associated with complete tooth loss (Fig. 4).
Total Case (N) Case (%) Control (N) Control (%) P
Cohort description 363 121 242
Demographic characteristics
Gender
Female 81 27 22.3 54 22.3 1.000
Male 282 94 77.7 188 77.7 1.000
Lifestyle Characteristics
Current/former 
cigarette usage # of cigarettes
Never 103 22 18.2 81 33.5 0.003
Slight former user 46 6 5.0 40 16.5 0.001
Never regular user 13 4 3.3 9 3.7 1.000
Former regular user 141 57 47.1 84 34.7 0.030
Current regular user 21/day (mean), 20/day (median) 60 32 26.4 28 11.6 <0.001
Current/former 
alcohol usage # of drinks/week
Never 8 5 4.1 3 1.2 0.123
Never regular or former regular 187 59 48.8 128 52.9 0.504
Current regular 22/week (mean), 8/week (median) 168 57 47.1 111 45.9 0.824
Health characteristics
Current tooth status
Has all or most of natural adult teeth 248 65 53.7 183 75.6 <0.001
Has partial plates or implants 37 11 9.1 26 10.7 0.715
Has full upper dentures or implants 21 10 8.3 11 4.5 0.160
Has full lower dentures or implants 1 0 0.0 1 0.4 1.000
Has upper and lower dentures 39 24 19.8 15 6.2 <0.001
NA 17 11 9.1 6 2.5 0.008
Oral rinse sample HPV status
Negative 82 63 52.1 19 7.9 <0.001
Positive 44 43 35.5 1 0.4 <0.001
NA 237 15 12.4 222 91.7 <0.001
Tumor HPV status
Negative HPV cDNA <3 or RPLP0 is not valuable 13 13 10.7
Positive HPV cDNA ≥3 and RPLP0 is evaluable 21 21 17.4
NA Missing 329 87 71.9 242 100.0
History of periodontitis
Negative 269 80 66.1 189 78.1 0.016
Positive 82 35 28.9 47 19.4 0.046
NA 12 6 5.0 6 2.5 0.225
Other information
Sequencing phase Plates
Phase1 1YXO, 1YXP, 1YXR, 1YXS 234 90 74.4 144 59.5 0.005
Phase2 SK-24Q7, SK-24Q8, IZGE 40 15 12.4 25 10.3 0.595
Phase3 SK-27BR 89 16 13.2 73 30.2 <0.001
Table 1. Cohort characteristics including case-control status, lifestyle, and health. P-values are two-tailed 
and correspond to Fisher’s exact tests for differential enrichment of categorical properties in cases relative to 
controls. As expected, most risk factors are significantly enriched in cancer cases.
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The broad shift in community composition was also reflected in a dramatic shift in function associated with 
tooth loss. Twenty-two metabolic pathways (Supplementary Dataset 5), including transport systems for sug-
ars (M00215: D-Xylose transport, M00216: Multiple sugar transport, M00217: D-Allose transport, M00198: 
Putative sn-glycerol-phosphate transport), metals (M00245: Cobalt/nickel transport, M00186: Tungstate trans-
port), and organic ions, such as glycine, betaine, and proline (M00208: Glycine betaine/proline transport), as 
well as modules involved in the synthesis of polyamines, including arginine, agmatine, ornithine, putrescine, 
and spermidine (M00133: Polyamine biosynthesis, arginine => agmatine => putrescine => spermidine, 
M00134: Polyamine biosynthesis, arginine => ornithine => putrescine) were lower in abundance in individuals 
with tooth loss. Other modules at lower abundance included those for the GABA gamma aminobutyrate shunt, 
Figure 1. Oral microbial community taxa and functional pathways differentially abundant in cancer. (a) Taxa 
(genera and OTUs) and (b) pathways differentially abundant in oral cancer microbiomes as determined by 
a multivariate model incorporating case/control status, tumor HPV status, tooth loss, periodontal disease, 
and other demographic and clinical covariates (see Methods). Differences are significant at FDR q < 0.25, and 
n = 121 cases, 242 controls (see Table 1, Supplementary Datasets 4 and 5).
www.nature.com/scientificreports/
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which channels glutamate into the TCA cycle (M00027: GABA (gamma-Aminobutyrate) shunt). In contrast, 
many pathways including the synthesis of threonine, asparate, and homoserine (M00018: Threonine biosynthe-
sis, aspartate => homoserine => threonine) and phosphoribosyl pyrophosphate (M00005: PRPP biosynthesis, 
ribose 5P => PRPP), which is involved in the synthesis of nucleotides (purines and pyrimidines), NAD, and the 
amino acids histidine and tryptophan, occurred at higher abundance among subjects with no remaining natu-
ral teeth. A gene level analysis of the Threonine biosynthesis pathway (M00018) revealed that most genes were 
altered in their relative abundance between individuals having at least some of their natural teeth and individuals 
with complete tooth loss (Fig. 5). Additionally, some of the genes from this pathway, e.g. K12525 (metL), K12526 
(lysAC), which are interchangeable within the process from L-Aspartate into L-4-Aspartylphosphate are specific 
to Gram-negative bacteria. Overall, complete tooth loss results in a significant change in the structure and func-
tion of the oral microbiome.
Tobacco smoking leads to a loss of diversity and increased glutamate metabolism in the oral 
microbiome. To analyze the influence of tobacco smoking on the oral microbiome, we identified clades and 
metabolic pathways that differed significantly in current regular smokers (60 individuals) and occasional or for-
mer smokers (200) compared to non-smokers (103; Table 1). This revealed 24 clades (Fig. 2a) and 12 metabolic 
pathways (Fig. 2b) that were altered in smokers compared to non-smokers (Supplementary Datasets 4 and 5) and 
an increased between-sample microbial diversity in smokers (Supplementary Fig. 1). Past smoking habits did not 
have a significant effect on the microbial community profile for most clades and pathways.
Most of the significant differences in clades were between regular smokers and non-smokers (24 clades). 
Comparing these groups, a broad range of genus-level clades were significantly increased in smokers, including 
Lactobacillus, Bifidobacterium, Atopobium, Prevotella, Streptococcus, and Veillonella. On the other hand, Rothia, 
Neisseria, and Lautropia were significantly decreased in regular smokers. Shifts observed in a few significant 
clades (5) among occasional or former smokers were concordant with the differences detected between regular 
smokers and non-smokers. One proposed explanation for these observations is that smoking disrupts niche sat-
uration of health-associated species, eliminating a subset of organisms, altering community composition, low-
ering alpha-diversity, and increasing beta-diversity. In line with this model, our data show an overall increased 
between-sample microbial diversity in smokers as compared to non-smokers (Supplementary Fig. 1).
Significant changes in functional modules were detected in smokers, specifically an increased abundance of 
transport systems, including sugar uptake (M00197: Putative fructooligosaccharide transport, M00216: Multiple 
sugar transport), phosphate uptake (M00222: Phosphate transport) and metal transport systems, such as manga-
nese, zinc, and iron (M00319: Manganese/zinc/iron transport). An increase in abundance of the GABA gamma 
aminobutyrate shunt was also detected again (M00027: GABA (gamma-Aminobutyrate) shunt), used by a variety 
of bacteria, in particular species of Streptococcus and Lactobacillus48,49, to cope with acid and oxidative stress50. 
Likewise, genes involved in amino acid degradation, specifically the conversion of histidine into glutamate, were 
also increased (M00045: Histidine degradation, histidine => N-formiminoglutamate => glutamate), indicating 
that pathways involved in glutamate metabolism are represented at higher levels in patients that smoke on a 
regular basis.
Figure 2. Microbial clades and pathways associated with oral cancer and with clinical, environmental, and 
demographic covariates. (a) Clades (tree includes all microbes in the dataset) and (b) pathways (shown on the 
KEGG BRITE hierarchy) differentially abundant with respect to oral cancer (highlighted points) and a subset of 
non-cancer covariates in this cohort (outer bands), comprising periodontal health, tumor HPV status, tobacco 
usage, and tooth status; multivariate model is as in Fig. 1 and Methods. Highlighted associations are significant 
at FDR q < 0.25, n as in Table 1.
www.nature.com/scientificreports/
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Limited structural changes and moderate functional implications tied to tumor HPV status, 
periodontitis, and alcohol consumption. Our multivariate model of cohort features associated with the 
microbiome included several other clinical and environmental factors (see Methods), but none of these showed 
evidence of associations as strong as those above for oral cancer or tooth loss (Table 1, Fig. 2). First, we assessed 
differences in microbial composition and function between patients with HPV-positive (35) and HPV-negative 
(55) oral cancer. Members of the Actinomyces, Granulicatella, Oribacterium, and Campylobacter genera as well as 
Veillonella dispar, Rothia mucilaginosa, and Haemophilus parainfluenzae were significantly increased in patients 
with HPV-positive cancers compared to non-HPV cancer patients.
In contrast, Streptococcus anginosus, Peptoniphilus, and Mycoplasma were significantly decreased in 
HPV-positive cancers. Functional changes in the oral microbial communities of HPV-positive vs. HPV-negative 
cancer patients included phosphonate transport (M00223: Phosphonate transport) and amino acid metabo-
lism through heme (M00121: Heme biosynthesis, glutamate => protoheme/siroheme), Shikimate (M00022: 
Shikimate pathway, phosphoenolpyruvate + erythrose-4P => chorismate), glutamate, and ornithine (M00028: 
Ornithine biosynthesis, glutamate => ornithine, Supplementary Dataset 5). We further investigated stratification 
of the oral cancer cases by site (oral vs. oropharyngeal) as well as HPV status, yielding 52 oral cancers of which 2 
(4%) were positive for HPV, 44 (85%) negative, and 6 (11%) unspecified; and 64 oropharyngeal cancers of which 
29 (45%) were HPV-positive, 10 (16%) negative, and 25 (39%) unspecified (5 cancer cases with unspecified sites 
were excluded from this analysis). Likely due to the small numbers resulting from this stratification, we did not 
identify any oral-oropharyngeal differences that were statistically significant after multiple hypothesis testing 
correction (Mann-Whitney U FDR q-value < 0.1). The same was true when stratifying the analysis by tumor 
HPV status.
Figure 3. Covariation of microbial community beta-diversity with non-cancer covariates including tooth loss, 
periodontal health, tumor HPV status, and tobacco usage. Ordination by non-parametric multidimensional 
scaling of samples’ Canberra dissimilarities, with oral/oropharyngeal cancer status indicated by shape and color 
stratified by (a) tooth loss status, (b) HPV positivity, (c) periodontal health, and (d) tobacco usage. Complete 
tooth loss represents the largest determinant of variability in the cohort’s oral microbial communities, with 
smaller effects of cancer case/control status and other covariates.
www.nature.com/scientificreports/
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Few significantly different clades were detected in patients with a history of periodontal disease (82 subjects) 
as compared to those without (269 subjects, Supplementary Dataset 4); only the Fusobacterium, Leptotrichiaceae, 
Eikenella, and Capnocytophaga genera were increased. Importantly, these are all Gram-negative bacte-
ria, in line with previous findings that periodontitis is characterized by a shift from primarily Gram-positive 
to Gram-negative organisms51. Likewise, at the functional level, few modules were consistently different 
(Supplementary Dataset 5). Genes for mannose uptake (M00276: PTS system, mannose-specific II component) 
Figure 4. Oral cancer and tooth loss significantly affect microbial community alpha- and beta-diversity. 
(a) Within-sample inverse Simpson alpha-diversity across all samples, and (b) between-sample Bray-Curtis 
dissimilarity between all pairs of samples within each phenotype. Stars indicate significant differences by 
Wilcoxon rank sum test (binary oral cancer status) or for Cuzick’s trend test (ordinal tooth loss status), both at 
p < 0.05.
Figure 5. Gene-level analysis of the serine biosynthesis, cysteine biosynthesis, and threonine biosynthesis 
pathways. The results of our study showed significant changes in the serine biosynthesis pathway (M00020) in 
cancer patients as compared with healthy individuals, cysteine biosynthesis pathway (M00338) in periodontitis 
patients, and the threonine biosynthesis pathway (M00018) in patients with complete tooth loss. Here, these 
pathways are shown on a gene level by visualizing the absolute difference in relative abundances of the genes 
(red color scheme), revealing that most genes from these pathways have been altered in their abundance 
between both conditions on a gene level. Additionally, we demonstrate that some of the genes from the 
threonine biosynthesis are either specific for Gram-negative (green) or Gram-negative/-positive bacteria (blue), 
while the serine and cysteine biosynthesis pathways consists of universal genes present in eukaryotes and 
prokaryotes.
www.nature.com/scientificreports/
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were less abundant; while subtle, this likely reflects the shift from a predominately Gram-positive community 
to Gram-negative, as sugar transport and metabolism is primarily attributed to the early tooth-colonizing 
Gram-positive streptococci. Interestingly, the higher abundance of Gram-negative anaerobes was associated with 
an increase in L-cysteine synthesis, both directly and indirectly through degradation of methionine (M00338: 
Cysteine biosynthesis, homocysteine + serine => cysteine, M00035: Methionine degradation). In addition to 
being an amino acid for protein synthesis, L-cysteine acts as an antioxidant and is also metabolized to hydrogen 
sulfide (H2S)52.
Finally, only one clade was significantly linked to alcohol consumption when comparing microbial profiles 
among current regular alcohol drinkers (168), former or irregular drinkers (187), and subjects never drinking 
alcohol (8, Supplementary Dataset 4). This represented an unclassified species in genus Capnocytophaga margin-
ally decreased in current regular drinkers. No changes in metabolic modules were associated with alcohol con-
sumption status, and even in targeted tests of only heavy (≥3 drinks per day) and non-drinkers, only two clades 
were enriched (Sharpea and unclassified Veillonellaceae) and one depleted (Lactococcus, Mann-Whitney U FDR 
q < 0.1). Notably, these were all relatively minor genera across the samples, and none of the differences in group 
means exceeded 0.1% relative abundance.
Discussion
In this study, we assessed structural and functional changes in the oral microbiome during oral cancer, in tan-
dem with clinical, demographic, and environmental covariates. This multivariate analysis remained well-powered 
compared to previous studies42,43 due to our sample size of over 120 oral cancer cases and twice as many matched 
controls. Few specific genera were consistently enriched or depleted during cancer, while functional shifts 
included decreased potential for microbial glutamate metabolism and metal (particularly iron) transport. The 
greatest dysbioses arose during tooth loss, particularly when no natural teeth remained, and other oral cancer 
risk factors including tobacco smoking, HPV infection, and periodontitis showed significant but smaller effects 
(Supplementary Dataset 4 and 8).
A small number of genera were differentially abundant during oral cancer, specifically Dialister (enriched) and 
Scardovia (depleted). Dialister are Gram-negative anaerobes within the family Veillonellaceae that have been asso-
ciated with worse periodontal status53 and endodontic infections54,55. They also appear to compete with species 
of Scardovia, as co-occurence analysis determined that these two genera infrequently inhabit the same niche56. 
Although previous sample sizes have been limited, earlier culture-based and culture-independent stud-
ies have also reported on oral bacteria disrupted on or in oral and esophageal tumors or in associated saliva 
samples42,43,46,57–61. In one study by Hooper et al.61, viable bacteria were detected within carcinoma tissues them-
selves. Our results generally agree with the enriched microbes, as well as those published by Pushalker et al., 
where bacterial colonization of tumor tissue and normal mucosa from the same subject were again found to be 
distinct43.
Previous studies suggested that poor oral hygiene could, in addition to increasing the risk of oral cancer16, 
influence the oral microbiome in cancer patients. The largest microbial effect in our cohort occurred during 
complete tooth loss, with progressive dysbioses with partial loss. The accompanying loss of community diversity 
was caused by the depletion of many clades known to inhabit a variety of distinct environments around the teeth 
(e.g. enamel, epithelial interface, or sub-gingival crevice), reducing Actinomycetaceae, Corynebacterium, Rothia, 
Prevotella, Flavobacteriales, Streptococcaceae, Fusobacteriales, and Proteobacteria and leaving a community of 
primarily Lactobacillales. Given the loss of habitats, the depletion of clades ranging up to the phylum level is 
unsurprising, as is the corresponding loss in inferred metagenomic functional potential.
Tobacco smoking also negatively influences oral health62,63 and can lead to oral cancer21,22,64. In par-
ticular, smoking can affect microbial biofilm structure and can result in unstable colonization compared to 
non-smokers62, increasing susceptibility to bacterial infections in smokers by dysregulation of the innate and 
adaptive immune responses63. Here, although microbial diversity changes associated with smokers were not 
statistically significant, we observed a trend toward increased overall between-sample diversity in smokers 
(Supplementary Fig. 1). This is in line with a previous study showing divergent microbial colonization patterns 
in smokers62. We likewise observed altered abundances of Firmicutes (Lactobacillus, Veillonella, Streptococcus), 
Actinobacteria (Bifidobacterium, Atopobium), Proteobacteria (Neisseria), and Bacteroidetes (Prevotella), also in 
agreement with previous findings26,62,65,66. Smoking may thus lead to a higher abundance of “misplaced” indige-
nous bacteria: depletion of niches typically colonized by commensal microbes and a greater incidence of atypical 
organisms, preventing stable biofilm formation and immune development.
HPV is similarly responsible for a large variety of cancer types67–70, including head and neck squamous cell 
carcinomas71. Previous studies have reported Streptococcus spp. as cofactors in the malignant transformation of 
oral keratinocytes by HPV72–75, although we detected relatively weak associations specific to HPV-positive oral 
cancers. Six metabolic pathways were significantly different, in addition to several clades including decreased 
Streptococcus anginous and Mycoplasma and increased Veillonella dispar. Previous studies have also suggested 
that Mycoplasma infection increases the rate of HPV infection, as well as the risk for abnormal cervical cytology 
and cancer76,77. Finally, glutamate metabolism and metal transport were, in contrast to other cancers, significantly 
increased in patients with HPV-positive tumors (as well as during several other indicators of poor oral health), 
in line with findings that report transglutaminase 2 (and other enzymes) as inhibitors of HPV78 or modulators of 
viral infections79,80.
Finally, periodontitis is an inflammatory condition resulting from a combination of microbial challenge 
and disregulated host immune response81. It is tightly linked to a shift to a higher proportion of Gram-negative 
anaerobes36–38 and is causally associated with oral cancer. In this study, four genus-level clades were signif-
icantly increased in individuals with periodontitis, namely Fusobacterium, Leptotrichiaceae, Eikenella, and 
Capnocytophaga. We detected a significant increase in abundance of the Gram-negative anaerobe Fusobacterium, 
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in agreement with previous findings82. In fact, the ability of Fusobacterium to manipulate the immune response 
and support the growth and colonization of both Eikenella and Capnocytophaga species (the other genera found 
at higher abundance) is well documented83, which speaks to the polymicrobial nature of periodontal disease. 
Information on the timing of periodontal disease in this cohort was not captured during the study (e.g. for-
mer vs. current), nor exact types of treatment received, which may be responsible for some of these differ-
ences as well. Overall, although some of the more usual suspects involved in periodontitis were not detected 
(e.g. Porphyromonas gingivalis, Tannerella forsythesis, Treponema denticola), the shift to a higher abundance of 
Gram-negative anaerobes is clearly in agreement with previous studies, and no additional dysbiotic interactions 
between periodontitis and cancer-linked microbes were detected.
Using a carefully controlled cohort, we were able to draw robust conclusions about associations between the 
oral microbiome and several disease states. By accounting for technical considerations such as sequencing batch 
effects and self-reporting limitations (e.g. for tobacco and alcohol consumption) during our analysis, we were able 
to demonstrate that the variances explained by the clinical factors are larger than those explained by batch effect. 
Thus, the relationships we observed are significant. Although the study design here permitted extensive testing 
of microbial dysbioses associated with oral cancer and its risk factors, as well as limited functional testing, much 
work remains in the analysis of the oral cancer microbiome. Causal factors and molecular mechanisms must be 
identified, with shotgun metagenomics (and/or metatranscriptomics) an obvious potential culture-independent 
follow-up. In addition to leveraging advances in sequencing methods, future studies should consider envi-
ronmental factors known to affect the microbiome more broadly (e.g. diet), which we were not able to assess. 
Ultimately, studies of the microbiome will combine greater molecular detail with larger population sizes and 
longitudinal monitoring to improve early detection and mitigation of microbial factors in oral cancer.
Methods
Participants. Eligible case subjects were identified from among consecutive patients diagnosed with oral 
cancer at the outpatient otolaryngology clinic of the Ohio State University Comprehensive Cancer Center 
(Columbus, OH) from July 2011 through May 2013. Patients were eligible for inclusion into the study if they were 
older than 17 years and were newly diagnosed with a histologically confirmed squamous cell carcinoma of the 
oral cavity or oropharynx. Anatomic site of origin was determined by a physical examination performed by the 
treating head and neck surgeon. Individuals with a prior history of head and neck cancer were ineligible.
Eligible controls included patients older than 17 years with no history of cancer who were evaluated as an out-
patient for any benign condition between August 2011 and August 2013 at the same otolaryngology service where 
cases were enrolled. This control population was considered to be representative of the referral population from 
which the case subjects were identified. After enrollment of a case subject, eligible control subjects in the same 
gender and age (5-year intervals) categories were invited to participate until two control subjects were individu-
ally matched to each case. The study protocol was approved by the Institutional Review Board of the Ohio State 
University and written informed consent was obtained from all study participants. All methods were performed 
in accordance with the relevant guidelines and regulations.
Oral rinse samples were collected from case subjects before the initiation of cancer therapy and from con-
trol subjects at enrollment. Oral rinse samples were collected by use of a 30-second rinse and gargle with either 
ScopeTM mouthwash or saline.
Detailed demographic and behavioral information was collected from all cases and controls using a 
computer-assisted interview programmed on a touch screen computer (Apple iPad). Domains included demo-
graphics, lifetime measures of tobacco, alcohol and marijuana use and medical and dental history. A “never” user 
of tobacco was defined as an individual who reported never having used any form of tobacco, including cigarettes, 
pipe, cigar, chewing tobacco or snuff. A current tobacco user was defined as reporting current use of one or more 
cigarettes per day or cigar, pipe or smokeless tobacco once or more a week. A “regular smoker” was defined as 
someone who ever smoked cigarettes daily for one month or more, or who used cigars, pipe or chewing tobacco 
at least once a week for six months or more. A “former user” is someone who reported they no longer did so at 
this interval when responding to the survey, making the minimal time frame since cessation one month for cig-
arette smokers and six months for other tobacco users. The median number of cigarettes per day among current 
smokers was 20 (IQR 12–27).
A “never” user of alcohol was defined as an individual who reported never having had a drink containing 
alcohol. A “current” alcohol user was defined as an individual who reported current consumption of one or more 
drinks per month. One “drink” of beer was defined as 12 ounces, wine as 5 ounces, and liquor as 1.5 ounces. The 
median number of drinks per week among current drinkers was 8 (IQR 2–20). An individual with a history of 
periodontitis was defined as an individual who reported having been told by a dental health provider that they 
had periodontitis. Current tooth status was self-reported in the specified categories.
An HPV-positive tumor was defined as a tumor positive for high-risk HPV E6 or E7 mRNA expression as 
previously described84. Briefly, samples were considered evaluable if DNA (ERV3) and mRNA (RPLPO, after 
reverse transcription) control templates could be amplified by qPCR and RT-PCR, respectively, after purification 
from formalin-fixed and paraffin-embedded tumor specimens. Tumor HPV status was determined by detection 
of HPV DNA of 15-high-risk types by consensus SPF10 primer system PCR amplification followed by reverse line 
blot hybridization (Inno-LiPa assay, Innogenetics). HPV DNA-positive samples were examined for the presence 
of E6 E7 mRNA expression of the corresponding HPV type by type-specific RT-PCR, and samples were consid-
ered positive if above the lower limit of assay reproducibility84.
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DNA extraction. Oral rinse samples were immediately placed at 4 °C and processed as previously described2. 
DNA was purified on a robotic, magnetic-bead based platform (QIAsymphony SP, Qiagen Inc.) using the 
QIAsymphony virus/bacteria Midi Kit and stored at −80 °C until further analysis.
16S rRNA gene sequencing. The 16S gene library consisted of Illumina MiSeq sequences targeting the 
V4 variable region. Detailed protocols used for 16S amplification and sequencing are as described before85. In 
brief, genomic DNA was subjected to 16S amplification using primers incorporating the Illumina adapters and a 
sample-specific barcode sequence, allowing directional sequencing covering variable region V4 (Primers: 515 F 
[GTGCCAGCMGCCGCGGTAA] and 806 R [GGACTACHVGGGTWTCTAAT]). PCR mixtures contained 
10 μl of diluted template (1:50), 10 μl of HotMasterMix with the HotMaster Taq DNA Polymerase (5 Prime), 
and 5 μl of primer mix (2 μM of each primer). The cycling conditions consisted of an initial denaturation of 94 °C 
for 3 min, followed by 30 cycles of denaturation at 94 °C for 45 sec, annealing at 50 °C for 60 sec, extension at 
72 °C for 5 min, and a final extension at 72 °C for 10 min. Amplicons were quantified on the Caliper LabChipGX 
(PerkinElmer, Waltham, MA), pooled in equimolar concentrations, size selected (375–425 bp) on the Pippin 
Prep (Sage Sciences, Beverly, MA) to reduce non-specific amplification products from host DNA, and a final 
library sizing and quantification was performed on an Agilent Bioanalyzer 2100 using DNA 1000 chips (Agilent 
Technologies, Santa Clara, CA). Sequencing was performed on the Illumina MiSeq v2 platform, according to the 
manufacturer’s specifications with addition of 5% PhiX, and generating paired-end reads of 150b in length in 
each direction. The overlapping paired-end reads were stitched together (approximately 97 bp overlap), and size 
selected to reduce non-specific amplification products from host DNA (22–275 bp).
To mitigate differences in detected microbial abundances arising for technical reasons among our three 
sequencing batches, we included sequencing phase as a covariate in all analyses. 124 microbial clades were signif-
icantly associated with batch identifier after adjusting for other covariates (case/control status, tooth status, etc.) 
and for multiple comparisons. Adjusting for this batch effect errs on the side of false negatives rather than false 
positives, but the loss in the power governs the type I error rate, implying that remaining non-batch associations 
are reliable.
Operational taxonomy unit (OTU) picking and taxonomy assignment. We used QIIME (version 
1.6.0)86 to perform OTU picking and taxonomy assignment as specified by PICRUSt87 (Supplementary Dataset 1). 
Specifically, we clustered the sequences from each sample into OTUs at 97% identity using UCLUST88 and 
matched reference sequences against Greengenes 13.589. The resulting OTU tables were checked for mislabeling90 
and contamination91, yielding mean sequence depth of 29,914 reads/sample. We finally applied PICRUST87 to 
predict gene family abundances from our 16S rRNA gene data (Supplementary Dataset 2, summary quality con-
trol statistics in Supplementary Dataset 9).
Metabolic pathway reconstruction. Inferred per-community gene abundances were subsequently 
reconstructed into microbial small metabolic modules, whose relative abundances were computed using 
HUMAnN92,93. We grouped KEGG orthologues into modules represented as gene sets and determined whether 
a module is present based on KEGG’s conjunctive normal form logic. Next, we computed each pathway’s relative 
abundance as a smoothed average over all genes, taking outliers and gap filling into account, which resulted in the 
relative abundances of modules within each sample. These sample-by-module relative abundances were subse-
quently treated in the same manner as sample-by-clade microbial abundances. We calculated nearest sequenced 
taxon index (NSTI) values [80] for all samples from this study, which ranged from a greatest distance of ~0.07 
through a minimum of ~0.01 and a mean of ~0.03, suggesting a Spearman correlation with underlying metagen-
omes between 0.7–0.9, well within the range of biological confidence (Supplementary Fig. 2).
Significant associations of microbial clades and pathways with sample metadata. OTU tables 
and reconstructed pathway abundance data were first processed for quality control. Clinical metadata features 
were not used if more than 10% of the data were missing, or when they did not vary in value over the available 
samples. Features (i.e. clades or pathways) of very low abundance (<0.001 in ≥90% of samples) as well as feature 
outliers (>3 × interquartile range in either direction) were removed as described previously92. After processing, 
363 samples passed quality control for clade and functional abundance analyses.
Clades and functions were tested for statistically significant associations with clinical metadata of interest using 
a multivariate analysis92,93. Here, the relative abundance of each clade was normalized with a variance-stabilizing 
arcsine square-root transformation and linked with the chosen covariates using a linear model, while the model 
selection for sparse data was performed per feature using boosting. A multivariate linear model (MaAsLin, http://
huttenhower.sph.harvard.edu/maaslin) associating all available metadata (including sequencing batch) with 
each clade was boosted independently, and any metadata selected in at least 1% of these iterations was tested 
for significance in a standard generalized linear model. Within each metadatum/feature association, multiple 
comparisons over factor levels were independently adjusted using a Bonferonni correction; multiple hypothesis 
tests over all features and metadata associations were adjusted on the Bonferonni corrected p-values to produce a 
final Benjamini and Hochberg false discovery rate (FDR). Unless otherwise indicated, significant association was 
considered below a FDR q-value of 0.25.
Features included in the multivariate linear model are listed in Supplementary Dataset 3 and comprise case/
control status, tooth loss status, tumor HPV status (for cases) by qPCR/RT-PCR/both, periodontal disease, dia-
betes status, cigarette and tobacco usage, alcohol consumption, microbial DNA concentration, whether a subject 
was born in the United States, race/ethnicity, age, and gender. All raw sequencing data are available from the SRA 
at BioProject number PRJNA321193.
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